Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:49 AM UTC
| NCT Number | NCT07003425 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 350 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Apogee Therapeutics, Inc. |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT07003425 is currently recruiting participants. This phase2 study for atopic dermatitis is actively seeking new participants at 22 locations across the United States. The study is sponsored by Apogee Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07003425 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07003425 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.